Active substance:
- Rabbit haemorrhagic disease virus, strain CAMP-V351, Inactivated
- Myxoma virus, strain CAMP V-219, Live
Route of administration:
-
Subcutaneous use
-
Subcutaneous use
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Target species:
-
Rabbit
-
Rabbit